Extendicare Inc.

TSX:EXE.TO

Medical - Care Facilities

Healthcare
$28.81 +2.61%

+$0.86 today

Market cap
$2.74B
Beta
1.16
P/E (TTM)
26.4
EPS (TTM)
$1.28
Dividend yield
1.51%
52W Low $12.12High $35.62

Volume 0.86M

Average 0.34M

EXE.TO EBITDA

Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.

Extendicare Inc.TSX: EXE.TO

EBITDA · Q2 FY2026 · quarter ended Jun 2026

EBITDA grows, but more slowly than its trailing trend

Q2 FY2026 EBITDA of CA$62.68M rose 15.5% year over year, behind the +28.5% change in trailing-twelve-month EBITDA. Sequentially, it rose 18.7% from the prior quarter. Over 3 fiscal years it compounded at +52.7% a year.

Context

  • EBITDA amounted to 10.6% of revenue in FY2025, unchanged from a year earlier.
  • EBITDA increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether EBITDA reaches the consensus estimate from 5 analysts of CA$288.17M (+64.1%) for the fiscal year ending Dec 2026, a step up from the +13.1% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterJun 2026
CA$62.68M+18.7% QoQ
Last fiscal yearDec 2025
CA$175.61M+13.1% YoY
LTMJun 2026
CA$213.41M+28.5% YoY
EBITDA past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+15.5%+65.7%+50.2 pp
1 year+13.1%+64.1%+51.0 pp
3-year CAGR+52.7%+28.1%-24.6 pp
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA history

CAD · from the income statement

Latest · FY2025
175.61M CAD
Year-over-year change
+13.1%
4-year CAGR
+23.7%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA vs competitors

How EXE.TO compares with its peers on the latest reported figures

  • Peers report in different currencies, so EBITDA is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +28.5% is the 4th highest of 7, against a peer median of +32.5%.
  • EBITDA amounts to 10.8% of revenue for EXE.TO, versus a peer median of 21.5%.
EXE.TO Competitors
EBITDA for EXE.TO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
WELL.TOWELL Health Technologies Corp.LTM Mar 2026CA$219.35M CAD+256.2%+29.6%14.9%
EXE.TOExtendicare Inc.LTM Jun 2026CA$213.41M CAD+28.5%+52.7%10.8%
SIA.TOSienna Senior Living Inc.LTM Sep 2026CA$202.95M CAD+39.8%+16.4%18.3%
DR.TOMedical Facilities CorporationLTM Mar 2026$75.52M USD-3.6%+5.1%24.7%
CRON.TOCronos Group Inc.LTM Mar 2026$47.83M USD+356.7%—30.0%
CRRX.TOCareRx CorporationLTM Mar 2026CA$30.12M CAD+25.2%—8.0%
TLRY.TOTilray Brands, Inc.LTM Feb 2026-$1.34B USD-106.7%—156.2%
Peer median (excluding EXE.TO) —+32.5%+16.4%21.5%

Competitors are the stored peer set for EXE.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

CAD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue1.17B1.22B1.3B1.47B1.66B
Cost of Revenue1.05B1.14B1.14B1.3B1.46B
Gross Profit115.61M76.83M167.62M168M199.59M
Gross Margin9.9%6.3%12.8%11.5%12.0%
Research & Development00000
Selling, General & Admin69.79M51.08M55.84M1.2B1.36B
Operating Expenses52.43M50.78M55.84M56.94M61.22M
Depreciation & Amortization38.57M32.12M32.23M33.34M37.25M
EBITDA75M49.33M98.63M155.27M175.61M
EBITDA Margin6.4%4.0%7.6%10.6%10.6%
Operating Income49.71M20.99M62.96M111.21M138.37M
Operating Margin4.3%1.7%4.8%7.6%8.3%
Interest Income1.87M5.02M6.19M7.04M5.73M
Interest Expense22.45M21.7M21.6M21.1M19.23M
Other Income / Expenses(35.72M)(25.48M)(18.16M)(11.35M)(8.26M)
Income Before Tax13.99M(4.5M)44.8M99.86M130.1M
Pre-Tax Margin1.2%-0.4%3.4%6.8%7.8%
Income Tax Expense6.48M15K10.82M24.65M33.45M
Net Income11.5M69.55M33.98M75.21M96.66M
Net Margin1.0%5.7%2.6%5.1%5.8%
EPS (Basic)0.130.850.400.971.13
EPS (Diluted)0.130.850.400.861.11
Weighted Avg Shares89.99M89.01M84.99M84.22M85.4M
Weighted Avg Shares (Diluted)100.9M89.01M84.99M95.36M86.84M

Extendicare Inc.

TSX:EXE.TO

Intrinsic Alpha fair value

Locked

Current Price

$28.81

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.